Nice to be back at London Calling in person Oxford Nanopore #NanoporeConf

WHO just published for the first time CONSOLIDATED guidelines on drug-susceptible #TB, also including a new recommendation on the use of a 4-month rifapentine-containing regimen (HPMZ) -- another first for TB! createsend.com/t/d-D008EFE5E3…

You probably have a few quid when this is what the stables looks like! Chatsworth

The gaf looks ok too, if your into that kind of thing

Good morning #Tbilisi , what a beautiful city! Over here to set up our drug resistant tuberculosis assay at the National Tuberculosis Centre

Wow, what an #ESHG2022 talk! #CRISPR-Cas9 causes off target structural variants in zebrafish NOT detected by short-read sequencing and ARE passed on to offspring. Huge implications to studies and any possible future therapeutic editing Paper is here: nature.com/articles/s4146…

The winner of this year’s Best Newcomer Award, sponsored by @co_garnier is… Oxford Nanopore. Huge congratulations on your very well deserved win! #winner #newcomer #MediscienceAwards

Two long read capable #NGS technologies compared side by side.

Great work from Mads Albertsen and colleagues assessing metagenomic assembly quality across DNA sequencing technologies (nature.com/articles/s4159…) it looks like Oxford Nanopore R10.4 no longer needs polishing with illumina (at least for bacteria) on both mock and real samples.

Useful update to the H37Rv reference genome for anyone handling M. tuberculosis sequence data #TB

Last week The Lancet published findings from the 2015 European Burden of Disease study, finding 70% of all DALYs were caused by four antibiotic-resistant bacteria. The paper advocates for #AMR stewardship and greater infection prevention Read more buff.ly/3BZYrvR

What is resistance in M. tuberculosis? New data on this from our large collaborative study linking WGS and MICs just published in Lancet Microbe FZ Borstel SRL Borstel DZIF (inaktiv) PMI TransEvo Matthias Merker Claudia Denkinger sciencedirect.com/science/articl…

Targeted genomic sequencing needed for rapid detection of DR-TB indianexpress.com/article/cities… BJGMC SGH PUNE Dr Rajesh Karyakarte Justin O'Grady

The customer workflows team Oxford Nanopore is still growing to help us deliver ISO accredited bioinformatics workflows for clinical applications. It's a really exciting time - help define our processes and build robust workflows. #bioinformatics #gemonics ejnh.fa.em2.oraclecloud.com/hcmUI/Candidat…

At Rhodes Trust Policy Summit today discussing “always on” pandemic preparedness rhodeshouse.ox.ac.uk/news-events/ev… Oxford Nanopore genomic surveillance is a “game changer” for health systems Justin O'Grady

Today Oxford Nanopore & bioMérieux, global leader in in vitro diagnostics, announce a new partnership to bring nanopore sequencing to the infectious disease diagnostics market: nanoporetech.com/about-us/news/… 1 /3

We are excited to enter into a research partnership with Oxford Nanopore in the field of infectious diseases. New technologies such as sequencing hold promise to improve diagnostics and patient care; our teams will collaborate in this direction. businesswire.com/news/home/2023…

Secretary of State Chloe Smith visited Oxford Nanopore to discover how their technology is already improving patient care. Today’s life science's announcements demonstrate our dedication to enhance people's lives and the economy by funding this important sector.

This week, the World Health Organization (WHO) announced its support of the use Oxford Nanopore's rapid test (in development) for profiling drug-resistant tuberculosis — a significant milestone in the fight against one of the most persistent threats in public health globally. bit.ly/3rJVJHy 🧵 1/5

🆕A rapid test in development by Oxford Oxford Nanopore in collaboration with the Quadram Institute is one of three sequencing-based tests for TB supported by WHO in a significant step in the global fight against infectious disease 🧬 Read more ➡️ buff.ly/3q9fgkf